Berli Jucker Public Company Limited Stocks

THB 14.5Last Updated 27.04.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

THB 1.80B

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
THB 14.5
Key Takeaways

Risk factor

Strong & resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Solid dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Berli Jucker Public Company Limited manufactures, distributes, and services in the areas of packaging, consumer, healthcare and technical, modern retail supply chain, and other group businesses in Thailand. It designs, manufactures, markets, and distributes glass and plastic packaging products, and aluminum cans. The company is involved in the distribution of personal care products, including Cellox facial tissues and toilet papers, Zilk toilet papers, Maxmo multi-purpose papers, Tasto potato chips, Dozo rice crackers, Party and Campus extruded snacks, Parrot soaps, and Dermapon baby soaps, as well as provides logistics management services, such as warehouse, transportation, customs brokerage, and freight forwarding representative services. In addition, it offers food products comprises snacks, beverages, packaged fruits, and dairy and yogurt products; and non-food products, which includes personal care, household products, stationery and office equipment, and others. Further, the company imports and distributes medicines, medical supplies, cosmeceuticals, pharmaceuticals, food supplements, and health products; medicines for treatment of various diseases such as kidney, hematology, cardiovascular, endocrine system, genitourinary system, skeleton, infection, oncology and tumors, pediatric medicines, and beauty products. It also offers medical devices, such as computed radiography systems, ultrasound systems, digital mammography systems, X-ray systems, 3D medical image processing systems, and laboratory information systems. Additionally, the company engages in bakery, food and nutraceutical, and cosmetic ingredients; industrial chemicals and refrigerants; e-commerce business; consultancy, design, installation, and the after-sales services for cranes and solar rooftop system; and weighing control system. The company was founded in 1882 and is headquartered in Bangkok, Thailand. Berli Jucker Public Company Limited is a subsidiary of TCC Corporation Company Limited.

Company Valuation

Slightly undervalued
5/7

From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral o

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of BJC.BK is 21 and suggests 44% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks